JOURNAL ARTICLE

Tick-borne illnesses in patients treated with B-cell depleting agents: Considerations for neurologists.

  • Published In: Multiple Sclerosis Journal, 2024, v. 30, n. 8. P. 1084 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Coban, Hamza 3 of 3

Abstract

B-cell depleting therapies, such as anti-CD20 and anti-CD19 agents, are commonly used to treat multiple sclerosis (MS) and other immune-mediated disorders. While these therapies are generally well tolerated, there is an increased risk of rare but severe tick-borne infections. Case reports have shown associations between tick-borne illnesses and B-cell depleting therapies, including babesiosis, Lyme disease, tick-borne encephalitis, Powassan encephalitis, and neo-ehrlichiosis. It is important for clinicians to be aware of this association, especially in endemic areas or for patients with a travel history to these areas. They should also inform patients about personal protective measures to prevent tick exposure and be prepared for atypical features in disease course, diagnosis, and treatment. [Extracted from the article]

Additional Information

  • Source:Multiple Sclerosis Journal. 2024/07, Vol. 30, Issue 8, p1084
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2024
  • ISSN:1352-4585
  • DOI:10.1177/13524585241237396
  • Accession Number:178718270
  • Copyright Statement:Copyright of Multiple Sclerosis Journal is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.